Anna McNay
Dermatology · Pleasanton, CANPI 1619947488
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by AbbVie at 39.8% of the total. Reporting peaked in 2023 at $8,067 and has fallen 63.2% since, to $2,970 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 680 payments — averaging $34.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- E.r. Squibb & Sons, L.L.C.$4K
- Johnson & Johnson$1K
- Incyte Corporation$928
- Dermavant Sciences, Inc.$823
- Sanofi$720
- plus $6K from 24 others
What the payments were for
- Consulting fees$4,09517%
- Speaking & faculty fees$6,69828%
- Travel & lodging$2531%
- Food & beverage$12,44952%
- Education$2431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 195 | $9,440 |
| E.r. Squibb & Sons, L.L.C. | 11 | $4,468 |
| Johnson & Johnson | 36 | $1,002 |
| Incyte Corporation | 48 | $928 |
| Dermavant Sciences, Inc. | 23 | $823 |
| Sanofi | 32 | $720 |
| Regeneron Healthcare Solutions, Inc. | 19 | $713 |
| Mayne Pharma Commercial LLC | 65 | $672 |
| Pfizer | 32 | $594 |
| Amgen | 30 | $520 |
| Boehringer Ingelheim | 18 | $443 |
| Sun Pharmaceutical Industries Inc. | 22 | $425 |
| Lilly USA, LLC | 14 | $385 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 21 | $353 |
| Galderma Laboratories, L.p. | 17 | $323 |
| VYNE Pharmaceuticals Inc. | 20 | $302 |
| EPI Health, LLC | 8 | $257 |
| Genentech USA, Inc. | 10 | $235 |
| Sandoz | 15 | $164 |
| UCB, Inc. | 7 | $163 |
| Novartis | 7 | $148 |
| LEO Pharma Inc. | 6 | $132 |
| Arcutis Biotherapeutics, Inc. | 5 | $112 |
| Almirall LLC | 4 | $101 |
| Journey Medical Corporation | 4 | $93 |
| Dermira, Inc. | 3 | $79 |
| Organon | 3 | $75 |
| Biofrontera Inc. | 3 | $33 |
| Hill Dermaceuticals, Inc. | 1 | $21 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sotyktu$4,303
- DUPIXENT$150
- Sitavig$119
- Cloderm$119
- Minolira 105mg$119
- Minolira 135mg$119
- Rhofade$119
- VTAMA$116
- Skyrizi$112
How this compares
$23,738 in reported general payments places this provider in the 90th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $49,857 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Pleasanton
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.